Total Funding
31
52
Total FundingPost-IPO Equity raised
Growth Score 31 in past quarter
-25 pts
Heat Score 52 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
279592
Pioneering advanced cancer diagnostics and regenerative medicine treatments.
- Hanne Evenbratt: Vice President, Research & Development
About the Company
Cline Scientific is a life science company that is dedicated to revolutionising medical solutions in cancer treatment and regenerative medicine, enhancing the lives of patients. Cline is actively advancing two transformative projects to clinical stages: StemCART, a stem cell therapy for joint repair, and CellRACE, a cancer diagnostic predicting
metastasis. With a strategic vision, Cline plans to collaborate with larger partners, facilitating the successful market launch of these innovative therapies for widespread impact.